Careprost Ls Bimatoprost Ophthalmic Solution

Careprost LS Bimatoprost Ophthalmic Solution

Careprost LS (Low Strength) Bimatoprost Ophthalmic Solution is a high-potency ocular intervention containing Bimatoprost, a synthetic structural analog of prostaglandin with potent hypotensive activity. Specifically engineered for the clinical management of open-angle glaucoma and ocular hypertension, this formulation works by concurrently increasing the outflow of aqueous humor through both the trabecular meshwork and the uveoscleral pathways. By neutralizing the biochemical triggers of elevated intraocular pressure (IOP), Careprost LS effectively facilitates the prevention of optic nerve damage and subsequent visual field loss. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of ocular fluid dynamics and promoting long-term stability in ophthalmic health.

Key Features

• Specifically formulated at a 0.01% concentration to target the receptors responsible for regulating aqueous humor outflow.
• Clinically recognized for its role in facilitating the alternative drainage pathways of the eye to significantly reduce IOP.
• Specifically engineered to provide therapeutic efficacy while reducing common side effects like conjunctival hyperemia (redness).
• Acts as a functional catalyst to stabilize internal eye pressure and prevent the progression of glaucomatous damage.
• Formulated to address chronic ocular hypertension caused by various physiological and genetic risk factors.

Key Ingredients

• Bimatoprost (0.01% w/v)
• Benzalkonium Chloride
• Sodium Chloride
• Sodium Phosphate
• Purified Water

Precautions

• This is a high-potency ophthalmic medication. Use must be strictly dictated by a healthcare professional after a full ophthalmic examination.
• Be advised that Bimatoprost can cause permanent darkening of the iris, the skin of the eyelid, and increase the thickness/length of eyelashes.
• Do not touch the dropper tip to any surface, including the eye or fingers, to maintain the sterile integrity of the solution.
• Remove contact lenses prior to application; they may be reinserted 15 minutes after administration to prevent absorption of the preservative.
• Discontinue use and consult a specialist if you experience sudden decreased visual acuity, ocular inflammation, or severe conjunctival edema.
• Keep the bottle tightly closed and store in a cool, dry place (between 2°C and 25°C). Protect from direct light to maintain the molecular stability of the active constituent.

How to Use

• Wash hands thoroughly and tilt the head back. Ensure the facial area is free from topical contaminants.
• Apply exactly one drop into the affected eye(s) as directed by your healthcare professional. Do not exceed the prescribed frequency.
• For optimal clinical results, administration should occur once daily, preferably in the evening, to align with the physiological cycles of ocular pressure.
• After applying the drop, apply gentle pressure to the nasolacrimal duct (the corner of the eye near the nose) for 1–2 minutes to limit systemic absorption.
• If using other ophthalmic medications, wait at least 5 minutes between applications to prevent the washout of active constituents.
• Maintain a regular application schedule. Premature cessation of the medication can lead to a dangerous rebound increase in intraocular pressure.

Legal Disclaimer: Careprost LS Bimatoprost Ophthalmic Solution is a specialized pharmacological intervention for ocular hypertension. Individual results vary based on the patient’s baseline eye health and the degree of pressure elevation. This product is for use under professional medical guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.